These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38958009)

  • 1. Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond.
    Hsu JC; Liu P; Song Y; Song W; Saladin RJ; Peng Y; Hu S; Lan X; Cai W
    Chem Soc Rev; 2024 Jul; 53(15):7657-7680. PubMed ID: 38958009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy.
    Li Z; Liu Y; Fang X; Shu Z
    Int J Nanomedicine; 2021; 16():1631-1661. PubMed ID: 33688183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy.
    Lee SN; Jin SM; Shin HS; Lim YT
    Acc Chem Res; 2020 Oct; 53(10):2081-2093. PubMed ID: 32966047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterials as Local Niches for Immunomodulation.
    Adu-Berchie K; Mooney DJ
    Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials to target immunity.
    Manchanda R; Fernandez-Fernandez A; Paluri SLA; Smith BR
    Adv Pharmacol; 2021; 91():293-335. PubMed ID: 34099112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Nanomaterials for Immunomodulation: A Review.
    Singh R; Kumawat M; Gogoi H; Madhyastha H; Lichtfouse E; Daima HK
    ACS Appl Bio Mater; 2024 Feb; 7(2):727-751. PubMed ID: 38166376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.
    Maisel K; Sasso MS; Potin L; Swartz MA
    Adv Drug Deliv Rev; 2017 May; 114():43-59. PubMed ID: 28694027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of Inducible Lymphoid Organs.
    Ruddle NH
    Curr Top Microbiol Immunol; 2020; 426():1-19. PubMed ID: 32588229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy.
    Wahab S; Ghazwani M; Hani U; Hakami AR; Almehizia AA; Ahmad W; Ahmad MZ; Alam P; Annadurai S
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions.
    Aljabali AAA; Obeid MA; Gammoh O; El-Tanani M; Mishra V; Mishra Y; Kapre S; Srivatsa Palakurthi S; Hassan SS; Nawn D; Lundstrom K; Hromić-Jahjefendić A; Serrano-Aroca Á; Redwan EM; Uversky VN; Tambuwala MM
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
    Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
    Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials for direct and indirect immunomodulation: A review of applications.
    Kubackova J; Zbytovska J; Holas O
    Eur J Pharm Sci; 2020 Jan; 142():105139. PubMed ID: 31704342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblastic reticular cells at the nexus of innate and adaptive immune responses.
    Perez-Shibayama C; Gil-Cruz C; Ludewig B
    Immunol Rev; 2019 May; 289(1):31-41. PubMed ID: 30977192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Cancer Chemo-Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials.
    Wang J; Li L; Xu ZP
    Small Methods; 2024 Jan; 8(1):e2301005. PubMed ID: 37743260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomaterials for T-cell cancer immunotherapy.
    Gong N; Sheppard NC; Billingsley MM; June CH; Mitchell MJ
    Nat Nanotechnol; 2021 Jan; 16(1):25-36. PubMed ID: 33437036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy.
    He X; Wang J; Tang Y; Chiang ST; Han T; Chen Q; Qian C; Shen X; Li R; Ai X
    Adv Healthc Mater; 2023 Sep; 12(23):e2300351. PubMed ID: 37289567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological nanomaterials to combat cancer metastasis.
    Pan Y; Cheng J; Zhu Y; Zhang J; Fan W; Chen X
    Chem Soc Rev; 2024 Jun; 53(12):6399-6444. PubMed ID: 38745455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
    Phuengkham H; Ren L; Shin IW; Lim YT
    Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.